1119 KEYSTONE WAY N., CARMEL, IN
Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
Five Directors Elected at Syra Health Corp Annual Meeting
Annual Report to Security Holders
Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position
Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026
Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth
Amendment to Certificate of Incorporation - Syra Health Corp
Annual Meeting Results - Five Directors Elected at Syra Health Corp.
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Effectiveness Notice
RW
S-1
Registration Statement for Securities to be Offered to Employees
SEC Form 25 - Delisting Notification
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload